These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 28880146)

  • 1. The physical dimensions of amyloid aggregates control their infective potential as prion particles.
    Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF
    Elife; 2017 Sep; 6():. PubMed ID: 28880146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physical basis of how prion conformations determine strain phenotypes.
    Tanaka M; Collins SR; Toyama BH; Weissman JS
    Nature; 2006 Aug; 442(7102):585-9. PubMed ID: 16810177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro analysis of SpUre2p, a prion-related protein, exemplifies the relationship between amyloid and prion.
    Immel F; Jiang Y; Wang YQ; Marchal C; Maillet L; Perrett S; Cullin C
    J Biol Chem; 2007 Mar; 282(11):7912-20. PubMed ID: 17234629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion amyloid structure explains templating: how proteins can be genes.
    Wickner RB; Shewmaker F; Edskes H; Kryndushkin D; Nemecek J; McGlinchey R; Bateman D; Winchester CL
    FEMS Yeast Res; 2010 Dec; 10(8):980-91. PubMed ID: 20726897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life cycle of yeast prions: propagation mediated by amyloid fibrils.
    Inoue Y
    Protein Pept Lett; 2009; 16(3):271-6. PubMed ID: 19275740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast.
    Villali J; Dark J; Brechtel TM; Pei F; Sindi SS; Serio TR
    Nat Struct Mol Biol; 2020 Jun; 27(6):540-549. PubMed ID: 32367069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Yeast prions, mammalian amyloidoses, and the problem of proteomic networks].
    Galkin AP; Mironova LN; Zhuravleva GA; Inge-Vechtomov SG
    Genetika; 2006 Nov; 42(11):1558-70. PubMed ID: 17163073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature dependence of the aggregation kinetics of Sup35 and Ure2p yeast prions.
    Sabaté R; Villar-Piqué A; Espargaró A; Ventura S
    Biomacromolecules; 2012 Feb; 13(2):474-83. PubMed ID: 22176525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism and application of molecular self-assembly in Sup35 prion domain of Saccharomyces cerevisiae].
    Yin W; He J; Yu Z; Wang J
    Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1401-7. PubMed ID: 22260056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sequence independence for prion formation.
    Ross ED; Edskes HK; Terry MJ; Wickner RB
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12825-30. PubMed ID: 16123127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic control of polyamines by the prion [PSI+].
    Namy O; Galopier A; Martini C; Matsufuji S; Fabret C; Rousset JP
    Nat Cell Biol; 2008 Sep; 10(9):1069-75. PubMed ID: 19160487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast prion protein New1 can break Sup35 amyloid fibrils into fragments in an ATP-dependent manner.
    Inoue Y; Kawai-Noma S; Koike-Takeshita A; Taguchi H; Yoshida M
    Genes Cells; 2011 May; 16(5):545-56. PubMed ID: 21453424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A size threshold limits prion transmission and establishes phenotypic diversity.
    Derdowski A; Sindi SS; Klaips CL; DiSalvo S; Serio TR
    Science; 2010 Oct; 330(6004):680-3. PubMed ID: 21030659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing the birth and propagation of two distinct prions, [PSI+] and [Het-s](y), in yeast.
    Mathur V; Taneja V; Sun Y; Liebman SW
    Mol Biol Cell; 2010 May; 21(9):1449-61. PubMed ID: 20219972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of yeast by infectious prion particles.
    King CY; Wang HL; Chang HY
    Methods; 2006 May; 39(1):68-71. PubMed ID: 16759879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sup35p in Its Soluble and Prion States Is Packaged inside Extracellular Vesicles.
    Kabani M; Melki R
    mBio; 2015 Aug; 6(4):. PubMed ID: 26286691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radically different amyloid conformations dictate the seeding specificity of a chimeric Sup35 prion.
    Foo CK; Ohhashi Y; Kelly MJ; Tanaka M; Weissman JS
    J Mol Biol; 2011 Apr; 408(1):1-8. PubMed ID: 21333653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth phase-dependent changes in the size and infectivity of SDS-resistant Sup35p assemblies associated with the [PSI
    Wang K; Melki R; Kabani M
    Mol Microbiol; 2019 Sep; 112(3):932-943. PubMed ID: 31206803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid fibrils embodying distinctive yeast prion phenotypes exhibit diverse morphologies.
    Ghosh R; Dong J; Wall J; Frederick KK
    FEMS Yeast Res; 2018 Sep; 18(6):. PubMed ID: 29846554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for transmission barrier and interference between closely related prion proteins in yeast.
    Afanasieva EG; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    J Biol Chem; 2011 May; 286(18):15773-80. PubMed ID: 21454674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.